生命科学资讯
生物技术与制药领域的最新动态
Labcorp, PathAI expand partnership to offer AI tech for digital pathology diagnostics
Abcuro's KLRG1 antibody flunks phase 2/3 muscle disease study
Allurion stock balloons as FDA signs off on its weight loss gastric system
Medtronic's diabetes business MiniMed eyes $784M IPO
Patient dies in MacroGenics' cancer study, FDA puts trial on hold
Beam Therapeutics' new PKU program; Protara's bladder cancer data
Abcuro drug fails muscle weakness trial, development to continue
Appointments and advancements for Feb. 24, 2026
Financings for Feb. 24, 2026
In the clinic for Feb. 24, 2026
Other news to note for Feb. 24, 2026
Regulatory actions for Feb. 24, 2026
How Enzymes Are Powering A New Generation of Micro-Robots
Immedica wins accelerated approval for once-rejected rare disease drug
Novo, searching for a spark, spotlights new data for three-pronged obesity drug
市场对赛默飞世尔科技公司的情绪如何？ - Benzinga
How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga
赛默飞世尔科技将在雷蒙德詹姆斯年度机构投资者大会上发表演讲——商业通讯
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference - Business Wire